Company profile: Summit Clinical Research
1.1 - Company Overview
Company description
- Provider of integrated non-alcoholic steatohepatitis (NASH) clinical research services, including site selection for top-enrolling trial sites and expedited start-up; site-specific pre-screening and enrollment strategies with branded recruitment; key opinion leader guidance and training; education, evidence generation, data dissemination and digital solutions; network site collaboration and support; and a Cirrhosis Advisory Board.
Products and services
- Key Opinion Leader Guidance: Delivers expert-led guidance from subject matter experts, trains investigators, sponsors, and CROs, and identifies barriers to enrollment in NASH trials
- Patient Enrollment: Architects site-specific pre-screening and enrollment strategies, produces site-branded recruitment materials, and supplies site support and training to accelerate NASH trial recruitment
- Site Selection: Engineers data-driven selection of top-enrolling NASH trial sites, leverages expansive NASH patient populations, and targets expedited start-up timelines to launch studies faster
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Summit Clinical Research
NeuroRx
HQ: Canada
Website
- Description: Provider of clinical trial services for new drugs in multiple sclerosis and other neurological diseases, including advanced MRI analysis; acquisition and analysis of non-conventional MRI (magnetization transfer imaging, magnetic resonance spectroscopy); MRI protocol guidance and manuals; compliant quantification forms; trial-specific scan tracking with validated database; site setup and supervision.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NeuroRx company profile →
Inclinix
HQ: United States
Website
- Description: Provider of customized Phase I-IV clinical trial enrollment solutions for pharmaceutical, biotechnology, and medical device organizations. A division of Inclinix-PMG Holdings, Inc., Inclinix combines the sites of PMG Research Inc. with premier patient recruitment solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inclinix company profile →
Clinical Trial Service
HQ: The Netherlands
Website
- Description: Provider of clinical research services as a private clinical research organization based in Losser.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinical Trial Service company profile →
Oruka Therapeutics
HQ: United States
Website
- Description: Provider of biologic therapies for chronic skin diseases, including monoclonal antibodies: ORKA-001 targeting IL-23p19 for psoriasis and other inflammatory diseases; ORKA-002 targeting IL-17A/F for psoriasis and other inflammatory diseases; and ORKA-003, a discovery-stage program for psoriasis, psoriatic arthritis, and related conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oruka Therapeutics company profile →
Paradigm Therapeutics
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies for rare diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Paradigm Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Summit Clinical Research
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Summit Clinical Research
2.2 - Growth funds investing in similar companies to Summit Clinical Research
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Summit Clinical Research
4.2 - Public trading comparable groups for Summit Clinical Research
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →